Trials / Completed
CompletedNCT00798538
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the feasibility, cost and effectiveness of interventions designed to integrate buprenorphine treatment for opioid dependence into HIV primary care in ten HIV care centers in the U.S. In the site led by Dr. Altice, we compare two models of providing HIV care and buprenorphine treatment. Assignments are based on participants' city of residence. In the onsite (integrated care) model, participants receive buprenorphine, substance abuse counseling and HIV care at one location: the Waterbury Hospital Infectious Disease Clinic. In the off-site model (non-integrated care) buprenorphine induction, substance abuse counseling, and HIV care will be provided at separate locations: the Community Health Care Van (CHCV), the Yale AIDS Program, and patients' own HIV providers, respectively. Data is collected from interviews with participants, reviews of medical records, and surveys and interviews with clinicians.
Conditions
- Buprenorphine
- HIV
- Drug Abuse
- Drug Addiction
- Drug Dependence
- Drug Use Disorders
- Drug Use Disorder
- Substance Abuse
- Opiate Addiction
- Substance-related Disorders
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Services will be provided at one site | Provision of buprenorphine induction and management, substance abuse counseling and HIV care will be provided at one clinic: the Waterbury Hospital Infectious Disease Clinic.. |
| OTHER | Services remain dispersed; i.e., not centralized to one-location or provider. | Buprenorphine induction, substance abuse counseling, and HIV care will be provided at separate locations: the Community Health Care Van (CHCV), the Yale AIDS Program, and patients' own HIV providers, respectively. |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2008-11-26
- Last updated
- 2015-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00798538. Inclusion in this directory is not an endorsement.